Trial · NCT03044912
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03044912, Phase 3, Unknown, Buddhist Tzu Chi General Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan. Trials, record NCT03044912. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03044912
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
- NCT number
- NCT03044912
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 574 participants, estimated
- Lead sponsor
- Buddhist Tzu Chi General Hospital
- Conditions
- Overactive Bladder Syndrome
- Interventions
- mirabegron
- First posted
- 2017-02-07
- Last updated
- 2017-02-09
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes of urgency episodes by 2 per 24 hours | baseline and 3 months | The percentage of patients with a change from baseline to the final visit in the urgency episodes per 24 hours by 2 or greater |
| Secondary | Net change of overactive bladder symptom score (OABSS) | baseline and 3 months | Net change from baseline to the final visit in OABSS score |
| Secondary | Patient Perception on Intensity of Urgency Scale (PPIUS) | baseline and 3 months | Net change of Patient Perception on Intensity of Urgency Scale (PPIUS) from baseline to the final visit |
| Secondary | Net change of mean number of frequency episodes | baseline and 3 months | The net change of mean number of frequency episodes from baselinbe to the final visit |
| Secondary | The net change of mean number of urinary incontinence episodes | baseline and 3 months | The net change of mean number of urinary incontinence episodes from baseline to the final visit |
| Secondary | Net change of the mean number of urgency incontinence episodes | baseline and 3 months | Net change of the mean number of urgency incontinence episodes from baseline to the final visit |
| Secondary | The net change of mean number of nocturia episodes per 24 hours | baseline and 3 months | The net change of mean number of nocturia episodes per 24 hours from baselinev to the final visit |
| Secondary | The net change of mean volume voided per micturition | baseline and 3 months | The net change of mean volume voided per micturition from baseline to the final visit |
| Secondary | The net change of the Patient Perception of the Bladder Condition (PPBC) | baseline and 3 months | The net change in the Patient Perception of the Bladder Condition (PPBC) from baseline to final visit |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03044912
GET https://conductscience.org/api/trials/v1/NCT03044912/registered